The odds for success in cancer drug's Multikine's upcoming phase III study are no better than a lottery ticket.
twocents@thestreet.com (Adam Feuerstein ), The Street
Thu, 02/11/2010 - 4:36am
The odds for success in cancer drug's Multikine's upcoming phase III study are no better than a lottery ticket.